Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 106

Results For "RMAT"

1288 News Found

DRiefcase app for Ayushman Bharat Digital Mission
Digitisation | January 31, 2022

DRiefcase app for Ayushman Bharat Digital Mission

ABDM is a digital framework that will connect patients, doctors and other healthcare stakeholders nationwide to facilitate safe and secure movement of health information


Union Budget 2022-23 : Industry expects increased allocation to healthcare, skill development, R&D and universal health insurance
Hospitals | January 30, 2022

Union Budget 2022-23 : Industry expects increased allocation to healthcare, skill development, R&D and universal health insurance

Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022


Union minister Mansukh Mandaviya launches NIPER website
Public Health | January 29, 2022

Union minister Mansukh Mandaviya launches NIPER website

The aim is to strengthen industry-academia cooperation


HealthPlix is in NASSCOM’s `League of 10’ companies 2021
Startup | January 28, 2022

HealthPlix is in NASSCOM’s `League of 10’ companies 2021

The award was given as a result of NASSCOM's meticulous screening process, in which over 700 start-ups were shortlisted as the most promising companies of the year


Mark Cuban’s online pharmacy set to disrupt drug prices in the US
News | January 27, 2022

Mark Cuban’s online pharmacy set to disrupt drug prices in the US

Direct to consumer pharmacy and formation as pharmacy benefit manager further mission to drastically expand access to affordable pharmaceuticals


Minimizing API losses critical to responsible pharma manufacturing
News | January 27, 2022

Minimizing API losses critical to responsible pharma manufacturing

Antibiotics mixed in wastewater often get disposed of into the water bodies resulting in wider antimicrobial resistance cases


USFDA rejects Merck’s gefapixant; gain approval in Japan
News | January 25, 2022

USFDA rejects Merck’s gefapixant; gain approval in Japan

Merck is studying the Complete Response Letter and it is not related to the safety of gefapixant


FDC’s chooses UFlex’ Asepto holographic packaging for Electral
Packaging | January 25, 2022

FDC’s chooses UFlex’ Asepto holographic packaging for Electral

The six-layer packaging ensures that external media such as bacteria, light and air do not contaminate the liquid


Biocon consolidated PAT at Rs 187.1 cr. in Q3FY22
News | January 21, 2022

Biocon consolidated PAT at Rs 187.1 cr. in Q3FY22

Biocon has reported consolidated financial results for the period ended December 31, 2021


US FDA approves Idorsia’s insomnia drug
Drug Approval | January 21, 2022

US FDA approves Idorsia’s insomnia drug

Quviviq is a dual orexin receptor antagonist, which blocks the binding of the wake-promoting neuropeptides orexins and is thought to turn down overactive wakefulness, as opposed to treatments that generally sedate the brain